Barely Significant
← all excerpts

Simufilam Reverses Aberrant Receptor Interactions of Filamin A in Alzheimer's Disease.

Int J Mol Sci · 2023 · PMC10531384 · PMID 37762230

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantp < 0.0001actually significant
For FLNA linkages to all three receptors in synaptosomes from AD versus age-, gender- and postmortem-interval-matched healthy control brain tissue, two-way ANOVAs showed highly significant main effects of diagnosis (CXCR4: F = 22.30, p < 0.0001; CD4: F = 188.52, p < 0.0001; CCR5: F = 179.43, p < 0.0001) and treatment (CXCR4: F = 44.39, p < 0.0001; CD4: F = 140.48, p < 0.0001; CCR5: F = 35.78, p < 0.0001) and a diagnosis–treatment interaction (CXCR4: F = 22.29, p < 0.0001; CD4: F = 109.68, p < 0.0001; CCR5: F = 79.78, p < 0.0001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.